<DOC>
	<DOC>NCT00296894</DOC>
	<brief_summary>Patients will be randomized into two groups (1/1) during one year: - 40 mg adalimumab subcutaneously (sc) every other week - placebo The effect on x-rays and clinical parameters will be evaluated.</brief_summary>
	<brief_title>Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Clear erosive image on xray of at least one interphalangeal finger joint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>